Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 9NIH 7INDUSTRY 2INDIV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1

Conditions

Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma 1Healthy Volunteer 1

Interventions

pembrolizumab 1033Carboplatin 971Paclitaxel 942Gemcitabine 799Cisplatin 757Docetaxel 698Bevacizumab 637Nivolumab 520Pemetrexed 507Capecitabine 475Cyclophosphamide 473Fluorouracil 425Dexamethasone 410Rituximab 391Oxaliplatin 352Injections 347Trastuzumab 314atezolizumab 312Cetuximab 291Leucovorin 290Irinotecan 271130-nm albumin-bound paclitaxel 257Prednisone 251Ipilimumab 244Doxorubicin 241Lenalidomide 231Fulvestrant 226fludarabine 219durvalumab 211Erlotinib Hydrochloride 196

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × keyhole-limpet hemocyanin × Clear all
NCT02947854 2019-08-28

Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/Adjuvant

PCI Biotech AS

Phase 1 Completed
96 enrolled

Healthy Volunteer

NCT00091676 2012-02-03

BiovaxID

Biovest International

Phase 3 Unknown
629 enrolled
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡